<!DOCTYPE html>
<html>
  <head>
    <link rel="stylesheet" href="styles.css" />
  </head>
  <body>
    <nav id="navbar">
      <header>Cardiac Medications</header>
      <ul>
        <li><a class="nav-link" href="#Introduction">Introduction</a></li>
        <li><a class="nav-link" href="#Receptors">Receptors</a></li>
        <li><a class="nav-link" href="#Inotropes">Inotropes</a></li>
        <li><a class="nav-link" href="#Chronotropes">Chronotropes</a></li>
        <li><a class="nav-link" href="#Dromotropes">Dromotropes</a></li>
        <li><a class="nav-link" href="#Bathmotropes">Bathmotropes</a></li>
        <li><a class="nav-link" href="#Lusitropes">Lusitropes</a></li>
        <li><a class="nav-link" href="#Vasopressors">Vasopressors</a></li>
        <li><a class="nav-link" href="#Cardiac_Meds_Table">Cardiac Meds Table</a></li>
        <li><a class="nav-link" href="#References">References</a></li>
      </ul>
    </nav>
    <main id="main-doc">
      <section class="main-section" id="Introduction">
        <header>Introduction</header>
        <article>
          <p>In the realm of cardiovascular pharmacology, understanding the nuanced roles of inotropes, chronotropes, dromotropes, bathmotropes, and lusitropes is crucial for optimizing patient care. 
            These categories of medications each target specific aspects of heart function.
          </p>
          <ul>
            <li>
                <b>Inotropes</b> enhance the force of cardiac contractions, making them vital in managing heart failure.
            </li>
            <li>
                <b>Chronotropes</b> influence heart rate, with agents like atropine increasing it and others like beta-blockers decreasing it.
            </li>
            <li>
                <b>Dromotropes</b> affect the conduction velocity through the AV node, crucial for treating arrhythmias; verapamil is a prime example.
            </li>
            <li>
                <b>Bathmotropes</b> modify the excitability of cardiac muscle cells, with epinephrine being a well-known agent that increases excitability.
            <li>
                <b>Lusitropes</b> improve myocardial relaxation, aiding in conditions where enhanced diastolic function is needed.
            </li>
            <li>
                <b>Vasopressors</b> Medications that constrict blood vessels to increase blood pressure, commonly used in the management of shock and severe hypotension
            </li>
          </ul>
          <p>Together, these medications provide a comprehensive toolkit for addressing a wide array of cardiovascular conditions, each with its unique mechanism and therapeutic application. Often times used in an array of cardiac surgeries. Check out my blog post on <a class="hyperlink" href="https://thrash.icu/mechanical-and-bioprosthetic-valves-cardiac-surgery">cardiac valve surgery</a>, comparing mechanical to bioprosthetic.
          </p>
          <p><code>To start off, its important to understand the receptors these medciations affect and where else they are on the body. If you activate one receptor with one specific intention, understanding the side effect (or in this case the unintended sequence of events) is imperative when prescribing anything.</code></p>
        </article>
      </section>
      <section class="main-section" id="Receptors">
        <header>Receptors</header>
        <figure><img src="https://i0.wp.com/thrash.icu/wp-content/uploads/2024/05/niccolai_a_chemistry_molecule_being_attached_to_a_receptor_in_5d386461-a81a-4e8b-8ca7-0dfaeadbca64_3.png?resize=1024%2C574&ssl=1"></figure>
        <article>
            <h3>Beta-1 Adrenergic Receptors</h3>
                <ul>
                    <li><b>Location:</b> Primarily Found in the heart.</li>
                    <li><b>Function:</b> Increase heart rate (chronotropy), increase force of contraction (inotropy), and increase conduction velocity (dromotropy)</li>
                </ul>
            <h3>Beta-2 Adrenergic Receptors</h3>
            <ul>
                <li><b>Location:</b> Found in the lungs, gastrointestinal tract, liver, uterus, vascular smooth muscle, and skeletal muscle.</li>
                <li><b>Function: </b>Bronchodilation, decrease gastrointestinal motility and tone, glycogenolysis, relaxation of uterine smooth muscle, vasodilation, enhance muscle contraction and increase potassium uptake.</li>
            </ul>
            <h3>Alpha-1 Adrenergic Receptors</h3>
            <ul>
                <li><b>Location:</b> Found in vascular smooth muscle.</li>
                <li><b>Function: </b>Vasoconstriction.</li>
            </ul>
            <h3>Alpha-2 Adrenergic Receptors</h3>
            <ul>
                <li><b>Location:</b> Found in presynaptic nerve terminals.</li>
                <li><b>Function: </b> Inhibition of norepinephrine release.</li>
            </ul>
            <h3>Dopaminergic Receptors (D1-like)</h3>
            <ul>
                <li><b>Location:</b> Found in the brain and kidneys.</li>
                <li><b>Function: </b>Modulate neurotransmission and renal blood flow.</li>
            </ul>
            <h3>Muscarinic Receptors</h3>
            <ul>
                <li><b>Location:</b> Found in various tissues including the heart.</li>
                <li><b>Function: </b>Decrease heart rate (M2 subtype), increase glandular secretions.</li>
            </ul>
            <h3>Calcium Channels</h3>
            <ul>
                <li><b>Location:</b> Found in cardiac and smooth muscle cells.</li>
                <li><b>Function: </b>Facilitate calcium influx which is crucial for muscle contraction.</li>
            </ul>
            <h3>Phosphodiesterase III (PDE3) Enzyme</h3>
            <ul>
                <li><b>Location:</b> Found in cardiac muscle, vascular smooth muscle, and platelets.</li>
                <li><b>Function: </b>Inhibition causes myocardial contractility and heart rate, vasodilation, inhibits platelet aggregation</li>
            </ul>
            <h3>V1 Receptors</h3>
            <ul>
                <li><b>Location:</b> Vascular smooth muscle, liver, platelets.</li>
                <li><b>Function: </b>Activations -> vascoconstriction, glycogenlysis, enhanced platelet aggregation
                </li>
            </ul>
            <h3>V2 Receptors</h3>
            <ul>
                <li><b>Location:</b> Renal collecting ducts</li>
                <li><b>Function: </b>Activation -> Increased water reabsorption by promoting the insertion of aquaporin-2 water channels into the apical membrane of collecting duct</li>
            </ul>
        </article>
      </section>
      <section class="main-section" id="Inotropes">
        <header>Inotropes</header>
        <article>
        <h2>Epinephrine</h2>
        <h3>Mechanism of Action</h3>
          <p>
            Epinephrine is a non-selective adrenergic agonist that stimulates alpha and beta adrenergic receptors. As an inotrope, its primary action is on beta-1 adrenergic receptors in the heart, leading to increased intracellular cAMP levels. This enhances calcium influx during systole, resulting in increased myocardial contractility (positive inotropy). Epinephrine also has effects on beta-2 receptors causing vasodilation and alpha-1 receptors causing vasoconstriction, which can influence overall vascular resistance depending on the dose.
          </p>
        <h3>Clinical Applications</h3>
          <p>
            Utilized in shock states including septic shock or cardiogenic shock, where it helps maintain blood pressure and organ perfusion. It is also used in severe asthma attacks when other treatments are ineffective, to improve bronchodilation and cardiac output. Additionally, in anaphylaxis, epinephrine counteracts severe allergic reactions by increasing heart rate and contractility and reducing systemic vasodilation.
          </p>
        <h3>Side Effects</h3>
          <p>
            Common side effects include tachycardia, arrhythmias, hypertension, palpitations, and potential exacerbation of myocardial ischemia on the cardiovascular system. Central nervous system side effects include anxiety, nervousness, tremors, and headache. Metabolic side effects involve hyperglycemia due to increased glycogenolysis and gluconeogenesis.
          </p>

          <h2>Milrinone (Primacor)</h2>
          <h3>Mechanism of Action</h3>
            <p>Dobutamine primarily stimulates beta-1 adrenergic receptors leading to increased myocardial contractility and stroke volume. This results in an overall improvement in cardiac output without significant changes in heart rate or systemic vascular resistance.</p>
          <h3>Clinical Applications</h3>
            <p>Dobutamine is commonly used in cases of acute heart failure or cardiogenic shock where enhanced cardiac output is desired.</p>
          <h3>Side Effects</h3>
            <p>Potential side effects include arrhythmias, increased myocardial oxygen consumption leading to ischemia, and hypotension.</p>

          <h2>Dopamine (Intropin)</h2>
          <h3>Mechanism of Action</h3>
          <p>Dopamine has dose-dependent effects:
            <ul>
            <li>Low doses stimulate dopaminergic receptors causing renal vasodilation.</li>
           <li>Intermediate doses stimulate beta-1 adrenergic receptors increasing cardiac contractility.</li>
            <li>High doses stimulate alpha-1 adrenergic receptors causing vasoconstriction.</li></ul></p>
          <h3>Clinical Applications</h3>
            <p>Dopamine is used in shock states where both improved cardiac output and blood pressure support are needed.</p>
          <h3>Side Effects</h3>
            <p>Potential side effects include tachycardia, arrhythmias, and peripheral ischemia at high doses due to vasoconstriction.</p>

          <h2>Digoxin (Digitek or Lanoxin)</h2>
          <h3>Mechanism of Action</h3>
            <p>Digoxin is a cardiac glycoside that inhibits the Na+/K+ ATPase pump in cardiac cells. This inhibition leads to an increase in intracellular sodium, which in turn increases intracellular calcium via the sodium-calcium exchanger, resulting in enhanced myocardial contractility (positive inotropy).</p>
          <h3>Clinical Applications</h3>
            <p>Digoxin is used for the treatment of heart failure and atrial fibrillation. It helps improve symptoms and exercise tolerance in heart failure patients and controls ventricular rate in atrial fibrillation.</p>
          <h3>Side Effects</h3>
                <p>Common side effects include nausea, vomiting, diarrhea, dizziness, visual disturbances (e.g., yellow-green halos), arrhythmias, and digoxin toxicity, which can be life-threatening if not managed properly.</p>
          <h2>Levosimendan (Simdax)</h2>
          <h3>Mechanism of Action</h3>
            <p>Levosimendan is a calcium sensitizer and PDE-3 inhibitor that enhances the sensitivity of cardiac troponin C to calcium. This action improves myocardial contractility without increasing intracellular calcium levels significantly. Additionally, it promotes vasodilation by opening ATP-sensitive potassium channels in vascular smooth muscle (positive lusitropy).</p>
          <h3>Clinical Applications</h3>
            <p>Levosimendan is used in acute decompensated heart failure to improve hemodynamics and symptoms. It has been shown to improve cardiac output and reduce preload and afterload.</p>
          <h3>Side Effects</h3>
          <p>Common side effects include hypotension, headache, dizziness, nausea, hypokalemia, and arrhythmias.</p>

          <h2>Enoximone (Perfan)</h2>
          <h3>Mechanism of Action</h3>
            <p>Enoximone is a PDE-3 inhibitor that increases intracellular cAMP levels in cardiac muscle cells. This leads to enhanced calcium reuptake into the sarcoplasmic reticulum, promoting myocardial relaxation (positive lusitropy) and improving contractility.</p>
          <h3>Clinical Applications</h3>
            <p>Enoximone is used in severe congestive heart failure to improve cardiac output and reduce symptoms. It is often considered when other treatments have failed or are not suitable.
            </p>
          <h3>Side Effects</h3>
          <p>Common side effects include arrhythmias, hypotension, gastrointestinal disturbances (e.g., nausea), thrombocytopenia, and liver enzyme elevations.</p>

          <h2>Pimobendan (Vetmedin)</h2>
          <h3>Mechanism of Action</h3>
            <p>Pimobendan is a calcium sensitizer and PDE-3 inhibitor that increases the sensitivity of cardiac myofilaments to calcium. This action enhances myocardial contractility (positive inotropy) without significantly increasing intracellular calcium levels. It also promotes vasodilation by inhibiting PDE-3 (positive lusitropy).</p>
          <h3>Clinical Applications</h3>
            <p>Pimobendan is used primarily in veterinary medicine for managing congestive heart failure in dogs due to dilated cardiomyopathy or mitral valve disease. Its use in human medicine is less common but may be considered in certain cases of heart failure.</p>
          <h3>Side Effects</h3>
          <p>Common side effects include gastrointestinal disturbances (e.g., vomiting), lethargy, anorexia, arrhythmias, and potential worsening of mitral valve regurgitation.</p>

        </article>
      </section>
      <section class="main-section" id="Chronotropes">
        <header>Chronotropes</header>
        <article>
          <h2>Atropine (AtroPen)</h2>
          <h3>Mechanism of Action</h3>
            <p>Atropine is an anticholinergic medication that inhibits muscarinic receptors (M2) on the heart leading to increased heart rate by blocking vagal influences on the sinoatrial node.</p>
          <h3>Clinical Application</h3>
            <p>Atropine is used to treat bradycardia (slow heart rate) especially in emergency settings like bradyarrhythmias or during resuscitation efforts.</p>
          <h3>Side Effects</h3>
            <p>Side effects can include dry mouth, blurred vision, urinary retention, constipation, and tachycardia.</p>

          <h2>Isoproterenol (Isuprel)</h2>
          <h3>Mechanism of Action</h3>
            <p>Isoproterenol is a non-selective beta agonist that stimulates both beta-1 and beta-2 adrenergic receptors leading to increased heart rate (positive chronotropy) and bronchodilation.</p>
          <h3>Clinical Application</h3>
            <p>Isoproterenol is used for bradycardia resistant to atropine and for certain types of heart block where pacemaker therapy is not immediately available.</p>
          <h3>Side Effects</h3>
            <p>Potential side effects include palpitations, arrhythmias, headache, dizziness, and tremors due to widespread beta receptor stimulation.</p>

          <p><code>Also Epinephrine and Dobutamine</code></p>
        </article>
      </section>
      <section class="main-section" id="Dromotropes">
        <header>Dromotropes</header>
        <article>
          <h2>Verapamil (Isoptin)</h2>
          <h3>Mechanism of Action</h3>
            <p>Verapamil is a calcium channel blocker that inhibits L-type calcium channels in cardiac cells leading to decreased conduction velocity through the atrioventricular node (negative dromotropy).</p>
          <h3>Clinical Application</h3>
            <p>Verapamil is used for controlling ventricular rate in atrial fibrillation/flutter and for treating supraventricular tachycardia (SVT).</p>
          <h3>Side Effects</h3>
            <p>Common side effects include hypotension, bradycardia, constipation, dizziness, and worsening heart failure in patients with reduced ejection fraction.</p>

            <h2>Diltiazem (Adizem)</h2>
          <h3>Mechanism of Action</h3>
            <p>Diltiazem also blocks L-type calcium channels but has a more balanced effect on both vascular smooth muscle and cardiac cells compared to verapamil. This leads to decreased AV nodal conduction (negative dromotropy) as well as some degree of vasodilation.</p>
          <h3>Clinical Application</h3>
            <p>Diltiazem is used similarly to verapamil for controlling ventricular rates in atrial fibrillation/flutter and for SVT management. It can also be used for angina due to its vasodilatory properties.</p>
          <h3>Side Effects</h3>
            <p>Potential side effects include bradycardia, hypotension, peripheral edema, dizziness, and gastrointestinal disturbances such as nausea or constipation.
            </p>
            <p><code>Positive Dromotropes include Isoproterenol and Atropine</code></p>
        </article>
      </section>

      <section class="main-section" id="Bathmotropes">
        <header>Bathmotropes</header>
        <article>
          <h2>Clonidine (Catapres)</h2>
          <h3>Mechanism of Action</h3>
            <p>Clonidine is an alpha-2 adrenergic agonist that stimulates alpha-2 receptors in the brainstem, leading to reduced sympathetic outflow from the central nervous system. This results in decreased peripheral vascular resistance and heart rate (negative chronotropy).</p>
          <h3>Clinical Application</h3>
            <p>Clonidine is used primarily for the treatment of hypertension. It can also be used for managing withdrawal symptoms in opioid dependence and as an adjunctive therapy for attention deficit hyperactivity disorder (ADHD).</p>
          <h3>Side Effects</h3>
            <p>Common side effects include dry mouth, drowsiness, dizziness, constipation, bradycardia, and rebound hypertension if abruptly discontinued.</p>

            <h2>Prazosin (Minipress)</h2>
          <h3>Mechanism of Action</h3>
            <p>Prazosin is an alpha-1 adrenergic antagonist that blocks alpha-1 receptors on vascular smooth muscle. This leads to vasodilation and decreased peripheral vascular resistance (negative bathmotropy).</p>
          <h3>Clinical Application</h3>
            <p>Prazosin is used for the treatment of hypertension and benign prostatic hyperplasia (BPH). It can also be used off-label for managing post-traumatic stress disorder (PTSD)-related nightmares.</p>
          <h3>Side Effects</h3>
            <p>Common side effects include orthostatic hypotension, dizziness, headache, drowsiness, nasal congestion, and palpitations.</p>

            <h2>Phenoxybenzamine (Dibenzyline)</h2>
          <h3>Mechanism of Action</h3>
            <p>Phenoxybenzamine is a non-selective alpha-adrenergic antagonist that irreversibly binds to alpha-1 and alpha-2 receptors. This blockade leads to vasodilation and decreased peripheral vascular resistance (negative bathmotropy).</p>
          <h3>Clinical Application</h3>
            <p>Phenoxybenzamine is used primarily for the management of pheochromocytoma to control hypertension and prevent hypertensive crises before surgery.</p>
          <h3>Side Effects</h3>
            <p>Common side effects include orthostatic hypotension, tachycardia, nasal congestion, fatigue, gastrointestinal disturbances (e.g., nausea), and miosis.</p>
          
        </article>
      </section>
      <section class="main-section" id="Lusitropes">
        <header>Lusitropes</header>
        <article>
          <h3>Milrinone</h3>
          <h3>Dobutamine</h3>
          <h3>Levosimendan</h3>
          <h3>Enoximone</h3>
        </article>
      </section>
      <section class="main-section" id="Vasopressors">
        <header>Vasopressors</header>
        <article>
          <h2>Phenylephrine (Biorphen or Vazculep)</h2>
          <h3>Mechanism of Action</h3>
            <p>Phenylephrine is a selective alpha-1 adrenergic agonist that causes vasoconstriction by stimulating alpha-1 receptors on vascular smooth muscle. This leads to increased systemic vascular resistance and blood pressure.</p>
          <h3>Clinical Application</h3>
            <p>Phenylephrine is used as a decongestant for nasal congestion, as a mydriatic agent for pupil dilation during eye examinations, and as a vasopressor for increasing blood pressure in hypotensive states.</p>
          <h3>Side Effects</h3>
            <p>Common side effects include hypertension, reflex bradycardia, headache, anxiety, tremors, and potential exacerbation of angina in patients with coronary artery disease.</p>

            <h2>Norepinephrine (Levophed)</h2>
          <h3>Mechanism of Action</h3>
            <p>Norepinephrine stimulates alpha-adrenergic receptors causing vasoconstriction as well as beta-1 adrenergic receptors increasing myocardial contractility.</p>
          <h3>Clinical Application</h3>
            <p>Norepinephrine is commonly used in septic shock or other forms of acute hypotension to increase blood pressure by vasoconstriction while supporting cardiac output.</p>
          <h3>Side Effects</h3>
            <p>Potential side effects include arrhythmias, hypertension, ischemia due to excessive vasoconstriction especially in peripheral tissues.</p>

            <h2>Vasopressin</h2>
          <h3>Mechanism of Action</h3>
            <p>Vasopressin is a synthetic form of antidiuretic hormone (ADH) that acts on V1 receptors in vascular smooth muscle to induce vasoconstriction and on V2 receptors in the renal collecting ducts to promote water reabsorption.</p>
          <h3>Clinical Application</h3>
            <p>Vasopressin is used in the management of vasodilatory shock (such as septic shock) to increase blood pressure by vasoconstriction. It is also used in cases of diabetes insipidus to reduce urine output and manage esophageal variceal bleeding by causing splanchnic vasoconstriction.</p>
          <h3>Side Effects</h3>
            <p>Potential side effects include hypertension, reduced cardiac output, ischemia (particularly in the gut, skin, and extremities), hyponatremia due to water retention, and headache.</p>

            <p><code>Also included is Epinephrine</code>
            </p>
          <p>Understanding the pharmacological actions of inotropes, chronotropes, and dromotropes is essential for effective cardiovascular management. These medications play pivotal roles in treating various cardiac conditions by targeting specific receptors throughout the body. By comprehending their mechanisms and clinical applications along with potential side effects, healthcare providers can make informed decisions to optimize patient outcomes.</p>
        </article>
      </section>
      <section class="main-section" id="Cardiac_Meds_Table">
        <header>Cardiac Meds Table</header>
        <article>
          <figure><img src="https://i0.wp.com/thrash.icu/wp-content/uploads/2024/05/image.png?resize=768%2C673&ssl=1"></figure>
        </article>
      </section>
      
      <section class="main-section" id="References">
        <header>References</header>
        <article>
          <ul>
            <li>
              <code>All the documentation in this page is taken from</code>
              <a
                href="https://thrash.icu/understanding-inotropes-and-vasopressors"
                target="_blank"
                >Thrash.ICU</a
              >
            </li>
          </ul>
        </article>
      </section>
    </main>
  </body>
</html>
